New Study in CHEST Validates the Cheetah Medical Inc. NICOM® 100% Non-Invasive Method for Addressing One of the Most Difficult Assessment Issues in Critical Care Medicine
9/5/2012 10:57:42 AM
More...
|
New Study From St. Elizabeth Health Center Trauma Team Demonstrates Value of Cheetah Medical Inc.'s NICOM® Bioreactance® Technology in Level I Trauma Center
8/14/2012 10:51:39 AM
More...
|
Cheetah Medical Inc.'s NICOM(R) Technology Featured in Duke Anesthesiology Study; New Findings of Efficacy to Guide Intraoperative Goal-Directed Fluid Therapy
6/12/2012 9:53:01 AM
More...
|
New Multicenter Study Seeking to Reduce the Devastating Impact of Sepsis Will Rely on Cheetah Medical Inc.'s NICOM(R) Non-Invasive Technology
2/13/2012 10:08:51 AM
More...
|
New Findings Reported by TJ Gan and Authors from Duke Anesthesiology Demonstrate Efficacy of Cheetah Medical Inc.'s NICOM(R) Bioreactance(R) Technology to Guide Goal Directed Intraoperative Therapy
10/17/2011 11:47:29 AM
More...
|
Cheetah Medical Inc. Closes $20 Million Series B Financing
3/15/2010 10:14:25 AM
More...
|
New Multicenter Study Finds That Cardiac Function Measured During Stress Testing With Cheetah Medical Inc.'s BIOREACTANCE(R) Noninvasive Technology Offers New Insights Into Heart Failure
10/2/2009 9:55:16 AM
More...
|
Cheetah Medical Inc.'s BIOREACTANCE(R) Noninvasive Hemodynamic Monitoring Technology Found to Be a Promising Early Diagnostic Tool for Identification of Acute Heart Failure in the Emergency Department
5/18/2009 10:32:58 AM
More...
|
Bruce J. Lewis Joins Growing Sales Management Team at Cheetah Medical Inc. – Leader in 100% Noninvasive Hemodynamic Monitoring Solutions Designed for Critical Care
3/4/2009 9:38:59 AM
More...
|
Cheetah Medical Inc. Announces FDA Clearance and US Release of NIBP Parameter for its NICOM(R) Hemodynamic Monitoring System
1/8/2009 7:15:06 AM
More...
|
|